The DOI matches its Crossref record; 128 of the 129 references it cites were found in a registry or an index.
An update on the mechanisms of the psychostimulant effects of caffeine
Open accessAbstract
There has been a long debate about the predominant involvement of the different adenosine receptor subtypes and the preferential role of pre‐ versus post‐synaptic mechanisms in the psychostimulant effects of the adenosine receptor antagonist caffeine. Both striatal A 1 and A 2A receptors are involved in the motor‐activating and probably reinforcing effects of caffeine, although they play a different role under conditions of acute or chronic caffeine administration. The present review emphasizes the key integrative role of adenosine and adenosine receptor heteromers in the computation of information at the level of the striatal spine module (SSM). This local module is mostly represented by the dendritic spine of the medium spiny neuron with its glutamatergic and dopaminergic synapses and astroglial processes that wrap the glutamatergic synapse. In the SSM, adenosine acts both pre‐ and post‐synaptically through multiple mechanisms, which depend on heteromerization of A 1 and A 2A receptors among themselves and with D 1 and D 2 receptors, respectively. A critical aspect of the mechanisms of the psychostimulant effects of caffeine is its ability to release the pre‐ and post‐synaptic brakes that adenosine imposes on dopaminergic neurotransmission by acting on different adenosine receptor heteromers localized in different elements of the SSM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In addition, functional interactions between A2A receptors and dopaminergic signaling pathways suggest that caffeine’s central stimulant effects likely arise from the broader disinhibition of a multi-neurotransmitter network, driven by concurrent antagonism of A1 and A2A receptors, rather than from blockade of a single receptor pathway alone [37,38].”
From Pre-Exercise Caffeine as a Modulator of Exercise-Induced Acute Cardiometabolic Responses: A Narrative Review (2026) · cites this paper as [37]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In addition, high concentrations of caffeine inhibit phosphodiesterase activity 3 and stimulate dopamine D2 receptors.9”
From Theanine maintains sleep quality in healthy young women by suppressing the increase in caffeine-induced wakefulness after sleep onset (2023) · cites this paper as [9]
Experimental — accuracy not yet measuredIn the citing paper
“Furthermore, caffeine excites neural circuits that project from the basal ganglia to the striatum and cerebral cortex.9”
From Theanine maintains sleep quality in healthy young women by suppressing the increase in caffeine-induced wakefulness after sleep onset (2023) · cites this paper as [9]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Dopamine, learning and motivation.
Wise, R. A. (2004) · Nature Reviews Neuroscience · doi:10.1038/nrn1406 · Cited by 3,379
Fredholm, B. B., Bättig, K., Holmén, J., Nehlig, A., & Zvartau, E. E. (1999) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01396-6 · Cited by 2,624
International Union of Pharmacology. XXV. Nomenclature and Classification of Adenosine Receptors
Fredholm, B. B., IJzerman, A. P., Jacobson, K. A., Klotz, K.-N., & Linden, J. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01511-4 · Cited by 2,585
Ungerstedt, U. (1971) · Acta Physiologica Scandinavica · doi:10.1111/j.1365-201x.1971.tb11000.x · Cited by 1,920
Ikemoto, S. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.05.004 · Cited by 1,477
Astrocytic Purinergic Signaling Coordinates Synaptic Networks
Pascual, O., Casper, K. B., Kubera, C., Zhang, J., Revilla-Sanchez, R., Sul, J.-Y., Takano, H., Moss, S. J., McCarthy, K., & Haydon, P. G. (2005) · Science · doi:10.1126/science.1116916 · Cited by 1,280
Mechanisms of neurotransmitter release by amphetamines: A review
Sulzer, D., Sonders, M. S., Poulsen, N. W., & Galli, A. (2005) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2005.04.003 · Cited by 1,243
Plasma membrane monoamine transporters: structure, regulation and function
Torres, G. E., Gainetdinov, R. R., & Caron, M. G. (2003) · Nature reviews. Neuroscience · doi:10.1038/nrn1008 · Cited by 936
Aggressiveness, hypoalgesia and high blood pressure in mice lacking the adenosine A2a receptor
Ledent, C. A., Vaugeois, J., Schiffmann, S. N., Pedrazzini, T., Yacoubi, M. E., Vanderhaeghen, J. J., Costentin, J., Heath, J. K., Vassart, G., & Parmentier, M. (1997) · Nature · doi:10.1038/41771 · Cited by 918
Adenosine–dopamine receptor–receptor interactions as an integrative mechanism in the basal ganglia
Ferré, S., Fuxé, K., Fredholm, B. B., Morelli, M., & Popoli, P. (1997) · Trends in Neurosciences · doi:10.1016/s0166-2236(97)01096-5 · Cited by 825
Self-citationRegulation of AMPA receptors during synaptic plasticity
Song, I., & Huganir, R. L. (2002) · Trends in Neurosciences · doi:10.1016/s0166-2236(02)02270-1 · Cited by 798
Coordinated Expression of Dopamine Receptors in Neostriatal Medium Spiny Neurons
Surmeier, D. J., Song, W., & Yan, Z. (1996) · Journal of Neuroscience · doi:10.1523/jneurosci.16-20-06579.1996 · Cited by 762
Adenosine receptors and behavioral actions of methylxanthines.
Snyder, S. H., Katims, J. J., Annau, Z., Bruns, R. F., & Daly, J. W. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.5.3260 · Cited by 694
Food sources and intakes of caffeine in the diets of persons in the United States
Frary, C. D., Johnson, R. K., & Wang, M. Q. (2005) · Journal of the American Dietetic Association · doi:10.1016/j.jada.2004.10.027 · Cited by 681
Adenosine and sleep–wake regulation
Basheer, R., Strecker, R. E., Thakkar, M. M., & McCarley, R. W. (2004) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2004.06.004 · Cited by 620
New roles for astrocytes: Regulation of synaptic transmission
Newman, E. A. (2003) · Trends in Neurosciences · doi:10.1016/s0166-2236(03)00237-6 · Cited by 619
Juliano, L. M., & Griffiths, R. R. (2004) · Psychopharmacology · doi:10.1007/s00213-004-2000-x · Cited by 613
PYCOCK, C. (1980) · Neuroscience · doi:10.1016/0306-4522(80)90048-2 · Cited by 610
Ciruela, F., Casadó, V., Rodrigues, R. J., Luján, R., Burgueño, J., Canals, M., Borycz, J., Rebola, N., Goldberg, S. R., Mallol, J., et al. (2006) · Journal of Neuroscience · doi:10.1523/jneurosci.3574-05.2006 · Cited by 591
Self-citationG-Protein-coupled receptor oligomerization and its potential for drug discovery
George, S. R., O’Dowd, B. F., & Lee, S. P. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd913 · Cited by 590
Caffeine as a psychomotor stimulant: mechanism of action
Fisone, G., Borgkvist, A., & Usiello, A. (2004) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-003-3269-3 · Cited by 558
Ferré, S., von Euler, G., Johansson, B., Fredholm, B. B., & Fuxé, K. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.16.7238 · Cited by 551
Self-citationHillion, J., Canals, M., Torvinen, M., Casadó, V., Scott, R. P., Terasmaa, A., Hansson, A. C., Watson, S. J., Olah, M. E., Mallol, J., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m107731200 · Cited by 499
Self-citationRashid, A. J., So, C. H., Kong, M. M. C., Furtak, T., El-Ghundi, M., Cheng, R., O’Dowd, B. F., & George, S. R. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0604049104 · Cited by 492
Astrocytic control of glutamatergic activity: astrocytes as stars of the show.
Hertz, L., & Zielke, H. (2004) · Trends in Neurosciences · doi:10.1016/j.tins.2004.10.008 · Cited by 490
Snyder, S. H. (1985) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.08.030185.000535 · Cited by 468
Porkka‐Heiskanen, T., Strecker, R. E., & McCarley, R. W. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00220-7 · Cited by 463
Valjent, E., Pagès, C., Hervé, D., Girault, J., & Caboche, J. (2004) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2004.03278.x · Cited by 453
Are we dependent upon coffee and caffeine? A review on human and animal data
Nehlig, A. (1999) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(98)00050-5 · Cited by 453
Adenosine A2A-Dopamine D2 Receptor-Receptor Heteromerization
Canals, M., Marcellino, D. J., Fanelli, F., Ciruela, F., de Benedetti, P., Goldberg, S. R., Neve, K. A., Fuxé, K., Agnati, L. F., Woods, A. S., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306451200 · Cited by 444
Self-citationDopamine D 1 and adenosine A 1 receptors form functionally interacting heteromeric complexes
Ginés, S., Hillion, J., Torvinen, M., Crom, S. L., Casadó, V., Canela, E. I., Rondin, S., Lew, J. Y., Watson, S. J., Zoli, M., et al. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.150241097 · Cited by 444
Self-citationHernández-López, S., Tkatch, T., Perez-Garci, E., Galarraga, E., Bargas, J., Hamm, H., & Surmeier, D. J. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-24-08987.2000 · Cited by 443
Fredholm, B. B., Irenius, E., Kull, B., & Schulte, G. (2001) · Biochemical Pharmacology · doi:10.1016/s0006-2952(00)00570-0 · Cited by 430
Robinson, T. E., Gorny, G., Mitton, E., & Kolb, B. E. (2001) · Synapse · doi:10.1002/1098-2396(20010301)39:3 · Cited by 411
Are Methylxanthine Effects Due to Antagonism of Endogenous Adenosine?
Fredholm, B. B. (1979) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(79)90046-4 · Cited by 409
Adenosine A2A receptors and basal ganglia physiology
Schiffmann, S. N., Fisone, G., Moresco, R. M., Cunha, R. A., & Ferré, S. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.05.001 · Cited by 393
Self-citationEffect of γ-butyrobetaine on fatty liver in juvenile visceral steatosis mice
Higashi, Y., Yokogawa, K., Takeuchi, N., Tamai, I., Nomura, M., Hashimoto, N., Hayakawa, J.-I., Miyamoto, K., & Tsuji, A. (2001) · Journal of Pharmacy and Pharmacology · doi:10.1211/0022357011775631 · Cited by 373
Heterodimerization of G Protein-Coupled Receptors: Specificity and Functional Significance
Prinster, S. C., Hague, C., & Hall, R. A. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.3.1 · Cited by 373
Lee, K.-W., Kim, Y. D., Kim, A. M., Helmin, K. A., Nairn, A. C., & Greengard, P. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0511244103 · Cited by 369
Adenosine-dopamine interactions in the brain
Ferré, S., Fuxé, K., von Euler, G., Johansson, B. A., & Fredholm, B. B. (1992) · Neuroscience · doi:10.1016/0306-4522(92)90291-9 · Cited by 366
Self-citationFerré, S., Karcz‐Kubicha, M., Hope, B. T., Popoli, P., Burgueño, J., Gutiérrez, M. A., Casadó, V., Fuxé, K., Goldberg, S. R., Lluı́s, C., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172393799 · Cited by 365
Self-citationCaffeine Induces Dopamine and Glutamate Release in the Shell of the Nucleus Accumbens
Solinas, M., Ferré, S., You, Z.-B., Karcz-Kubicha, M., Popoli, P., & Goldberg, S. R. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-15-06321.2002 · Cited by 338
Agnati, L. F., Ferré, S., Lluı́s, C., Franco, R., & Fuxé, K. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.3.2 · Cited by 323
Self-citationYacoubi, M. E., Ledent, C. A., Ménard, J.-F., Parmentier, M., Costentin, J., & Vaugeois, J. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703170 · Cited by 307
Principles of Addiction Medicine
Matthews, A. (2004) · JAMA · doi:10.1001/jama.291.1.112-b · Cited by 278
Adenosine receptor ligands: differences with acute versus chronic treatment
Jacobson, K. A., Lubitz, D. K. J. E. V., Daly, J. W., & Fredholm, B. B. (1996) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(96)10002-x · Cited by 265
Novel Neurotransmitters and Their Neuropsychiatric Relevance
Snyder, S. H., & Ferris, C. D. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.11.1738 · Cited by 263
Carriba, P., Ortiz, O., Patkar, K. A., Justinová, Z., Stroik, J., Themann, A., Müller, C. E., Woods, A. S., Hope, B. T., Ciruela, F., et al. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301375 · Cited by 260
Self-citationThe striopallidal neuron: a main locus for adenosine-dopamine interactions in the brain
Ferré, S., O'Connor, W. T., Fuxé, K., & Ungerstedt, U. (1993) · Journal of Neuroscience · doi:10.1523/jneurosci.13-12-05402.1993 · Cited by 251
Self-citationEffects of caffeine on performance and mood: withdrawal reversal is the most plausible explanation
James, J. E., & Rogers, P. J. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0084-6 · Cited by 231
Prostaglandins and adenosine in the regulation of sleep and wakefulness
Huang, Z., Urade, Y., & Hayaishi, O. (2006) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2006.09.004 · Cited by 227
The Role of Dopamine in the Behavioral Effects of Caffeine in Animals and Humans
Garrett, B. E., & Griffiths, R. R. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(96)00435-2 · Cited by 226
Caffeine and the dopaminergic system
Cauli, O., & Morelli, M. (2005) · Behavioural Pharmacology · doi:10.1097/00008877-200503000-00001 · Cited by 196
Svenningsson, P., Lindskog, M., Ledent, C. A., Parmentier, M., Greengard, P., Fredholm, B. B., & Fisone, G. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.4.1856 · Cited by 196
Karcz-Kubicha, M., Antoniou, K., Terasmaa, A., Quarta, D., Solinas, M., Justinova, Z., Pezzola, A., Reggio, R., Müller, C. E., Fuxe, K., et al. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300167 · Cited by 189
Self-citationLeenders, A. G. M., & SHENG, Z. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.10.012 · Cited by 181
Adenosine A2A receptor stimulation enhances striatal extracellular glutamate levels in rats
Popoli, P., Betto, P., Reggio, R., & Ricciarello, G. (1995) · European Journal of Pharmacology · doi:10.1016/0014-2999(95)00679-6 · Cited by 181
Involvement of DARPP-32 phosphorylation in the stimulant action of caffeine
Lindskog, M., Svenningsson, P., Pozzi, L., Kim, Y. D., Fienberg, A. A., Bibb, J. A., Fredholm, B. B., Nairn, A. C., Greengard, P., & Fisone, G. (2002) · Nature · doi:10.1038/nature00817 · Cited by 180
8‐(3‐Chlorostyryl)caffeine (CSC) is a selective A2‐adenosine antagonist in vitro and in vivo
Jacobson, K. A., Nikodijević, O., Padgett, W. L., Gallo‐Rodriguez, C., Maillard, M. C., & Daly, J. W. (1993) · FEBS Letters · doi:10.1016/0014-5793(93)81466-d · Cited by 173
Hervé, D., Moine, C. L., Corvol, J., Belluscio, L., Ledent, C. A., Fienberg, A. A., Jaber, M., Studler, J., & Girault, J. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-12-04390.2001 · Cited by 172
Fuxé, K., & Ungerstedt, U. (1974) · PubMed · Cited by 171
Lupica, C. R., Cass, W. A., Zahniser, N. R., & Dunwiddie, T. V. (1990) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20171-9 · Cited by 169
Svenningsson, P., Nomikos, G. G., Ongini, E., & Fredholm, B. B. (1997) · Neuroscience · doi:10.1016/s0306-4522(97)00046-8 · Cited by 169
Quarta, D., Ferré, S., Solinas, M., You, Z., Hockemeyer, J., Popoli, P., & Goldberg, S. R. (2004) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.02245.x · Cited by 163
Self-citationImpaired D2 Dopamine Receptor Function in Mice Lacking Type 5 Adenylyl Cyclase
Lee, K.-W., Hong, J. H., Choi, I. Y., Che, Y., Lee, J.-K., Yang, S.-D., Song, C.-W., Kang, H. S., Lee, J.-H., Noh, J. S., et al. (2002) · Journal of Neuroscience · doi:10.1523/jneurosci.22-18-07931.2002 · Cited by 163
Anatomy of adenosine A2Areceptors in brain
Rosin, D. L., Hettinger, B. D., Lee, A., & Linden, J. M. (2003) · Neurology · doi:10.1212/01.wnl.0000095205.33940.99 · Cited by 162
Adenosine A1 and A2 receptors modulate extracellular dopamine levels in rat striatum
Okada, M., Mizuno, K., & Kaneko, S. (1996) · Neuroscience Letters · doi:10.1016/0304-3940(96)12780-4 · Cited by 158
Functional relevance of neurotransmitter receptor heteromers in the central nervous system
Ferré, S., Ciruela, F., Woods, A. S., Lluı́s, C., & Franco, R. (2007) · Trends in Neurosciences · doi:10.1016/j.tins.2007.07.001 · Cited by 157
Self-citationRegulation of phosphorylation of the GluR1 AMPA receptor by dopamine D2 receptors
Håkansson, K., Galdi, S., Hendrick, J. P., Snyder, G. L., Greengard, P., & Fisone, G. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03558.x · Cited by 156
Ferré, S., O'Connor, W. T., Svenningsson, P., Björklund, L., Lindberg, J., Tinner, B., Strömberg, I., Goldstein, M., Ögren, S. O., Ungerstedt, U., et al. (1996) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.1996.tb01617.x · Cited by 146
Self-citationJarvis, S. E., & Zamponi, G. W. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01800-9 · Cited by 143
Postsynaptic antagonistic interaction between adenosine A1, and dopamine D1 receptors
Ferré, S., Popoli, P., Giménez‐Llort, L., Finnman, U.-B., Martı́nez, E., de Carolis, A. S., & Fuxé, K. (1994) · Neuroreport · doi:10.1097/00001756-199412300-00020 · Cited by 138
Self-citationAdenosine A2A receptors in ventral striatum, hypothalamus and nociceptive circuitry
Ferré, S., Diamond, I., Goldberg, S. R., Yao, L., Hourani, S. M. O., Huang, Z., Urade, Y., & Kitchen, I. (2007) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2007.04.002 · Cited by 135
Self-citationSolinas, M., Panlilio, L. V., Justinová, Z., Yaşar, S., & Goldberg, S. R. (2006) · Nature Protocols · doi:10.1038/nprot.2006.167 · Cited by 134
Metabotropic mGlu5 receptors regulate adenosine A 2A receptor signaling
Nishi, A., Liu, F., Matsuyama, S., Hamada, M., Higashi, H., Nairn, A. C., & Greengard, P. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0237126100 · Cited by 134
Caffeine alters plasma adenosine levels
Conlay, L. A., Conant, J. A., deBros, F., & Wurtman, R. (1997) · Nature · doi:10.1038/38160 · Cited by 133
Adenosine/dopamine interaction: implications for the treatment of Parkinson's disease
Ferré, S., Popoli, P., Giménez‐Llort, L., Rimondini, R., Müller, C. E., Strömberg, I., Ögren, S. O., & Fuxé, K. (2001) · Parkinsonism & Related Disorders · doi:10.1016/s1353-8020(00)00063-8 · Cited by 130
Self-citationOkada, M., Kiryu, K., 河田, 祐., Mizuno, K., Wada, K., Tasaki, H., & Kaneko, S. (1997) · European Journal of Pharmacology · doi:10.1016/s0014-2999(96)00938-7 · Cited by 130
Reinforcing effects of caffeine in humans.
Griffiths, R. R., & Woodson, P. P. (1988) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21004-7 · Cited by 127
Adenosine Receptor Subtypes Modulate Two Major Functional Pathways for Hippocampal Serotonin Release
Okada, M., Nutt, D., Murakami, T., Zhu, G., 鎌田, 晃., 河田, 祐., & Kaneko, S. (2001) · Journal of Neuroscience · doi:10.1523/jneurosci.21-02-00628.2001 · Cited by 121
Quarta, D., Borycz, J., Solinas, M., Patkar, K. A., Hockemeyer, J., Ciruela, F., Lluı́s, C., Franco, R., Woods, A. S., Goldberg, S. R., et al. (2004) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2004.02761.x · Cited by 120
Self-citationKull, B., Ferré, S., Arslan, G., Svenningsson, P., Fuxé, K., Owman, C., & Fredholm, B. B. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00184-7 · Cited by 118
Self-citationBorycz, J., Pereira, M. F., Melani, A., Rodrigues, R. J., Köfalvi, A., Panlilio, L. V., Pedata, F., Goldberg, S. R., Cunha, R. A., & Ferré, S. (2006) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04386.x · Cited by 118
Self-citationFerré, S., Torvinen, M., Antoniou, K. M., Irenius, E., Civelli, O., Arenas, E., Fredholm, B. B., & Fuxé, K. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.8.4718 · Cited by 117
Self-citationFerré, S., Agnati, L. F., Ciruela, F., Lluı́s, C., Woods, A. S., Fuxé, K., & Franco, R. (2007) · Brain Research Reviews · doi:10.1016/j.brainresrev.2007.01.007 · Cited by 116
Self-citationRole of adenosine receptors in caffeine tolerance.
Holtzman, S. G., Mante, S., & Minneman, K. P. (1990) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)23061-0 · Cited by 115
Nehlig, A., & Boyet, S. (2000) · Brain Research · doi:10.1016/s0006-8993(99)02480-4 · Cited by 106
Ferré, S., Herrera‐Marschitz, M., Grabowska‐Andén, M., Casas, M., Ungerstedt, U., & Andén, N. (1991) · European Journal of Pharmacology · doi:10.1016/0014-2999(91)90065-x · Cited by 105
Self-citationJiang, H., Jackson-Lewis, V. R., Muthane, U. B., Dollison, A. M., Ferreira, M., Espinosa, A., Parsons, B., & Przedborski, S. (1993) · Brain Research · doi:10.1016/0006-8993(93)90925-d · Cited by 99
Gubitz, A. K., Widdowson, L., Kurokawa, M., Kirkpatrick, K. A., & Richardson, P. J. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.67010374.x · Cited by 97
Adenosine agonists can both inhibit and enhance in vivo striatal dopamine release
Zetterström, T., & Fillenz, M. (1990) · European Journal of Pharmacology · doi:10.1016/0014-2999(90)90601-2 · Cited by 94
Stanwood, G. D., Parlaman, J. P., & Levitt, P. R. (2006) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2006.04970.x · Cited by 92
Mumford, G. K., & Holtzman, S. G. (1991) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)20490-6 · Cited by 90
Blocking Striatal Adenosine A2A Receptors: A New Strategy for Basal Ganglia Disorders
Müller, C. E., & Ferré, S. (2007) · Recent Patents on CNS Drug Discovery · doi:10.2174/157488907779561772 · Cited by 86
Self-citationStrömberg, I., Popoli, P., Müller, C. E., Ferré, S., & Fuxé, K. (2000) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2000.00288.x · Cited by 85
Self-citationGerfen, C. R. (2004) · The Rat Nervous System · doi:10.1016/b978-012547638-6/50019-5 · Cited by 85
Halldner, L., Ådén, U., Dahlberg, V., Johansson, B. A., Ledent, C. A., & Fredholm, B. B. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.01.014 · Cited by 84
Durcan, M. J., & Morgan, P. F. (1989) · European Journal of Pharmacology · doi:10.1016/0014-2999(89)90789-9 · Cited by 80
Cocaine and Caffeine Conditioned Place Preference, Locomotor Activity, and Additivity
Bedingfield, J. B. (1998) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(98)00092-6 · Cited by 79
Cortical connections of striate and extrastriate visual areas in tree shrews
Lyon, D. C., Jain, N., & Kaas, J. H. (1998) · The Journal of Comparative Neurology · doi:10.1002/(sici)1096-9861(19981109)401:1 · Cited by 78
Popoli, P., Giménez‐Llort, L., Pèzzola, A., Reggio, R., Martı́nez, E., Fuxé, K., & Ferré, S. (1996) · Neuroscience Letters · doi:10.1016/s0304-3940(96)13143-8 · Cited by 74
Self-citationCorsi, C., Melani, A., Bianchi, L., & Pedata, F. (2000) · Neuroreport · doi:10.1097/00001756-200008030-00048 · Cited by 73
Shindou, T., Nonaka, H., Richardson, P. J., Mori, A., Kase, H., & Ichimura, M. (2002) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0704702 · Cited by 71
Antoniou, K., Papadopoulou‐Daifoti, Z., Hyphantis, T. N., Papathanasiou, G., Bekris, E., Μαρσέλος, Μ., Panlilio, L. V., Müller, C. E., Goldberg, S. R., & Ferré, S. (2005) · Psychopharmacology · doi:10.1007/s00213-005-0173-6 · Cited by 69
Self-citationPsychostimulants and monoamine transporters: upsetting the balance
Elliott, J. M., & Beveridge, T. J. R. (2004) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2004.09.005 · Cited by 65
Popoli, P., Reggio, R., Pèzzola, A., Fuxé, K., & Ferré, S. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00533-3 · Cited by 62
Self-citationWood, P. L. (1989) · Neuropharmacology · doi:10.1016/0028-3908(89)90062-2 · Cited by 60
Caffeine and accumbens shell dopamine
Luca, M. A. D., Bassareo, V., Bauer, A., & Chiara, G. D. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04754.x · Cited by 56
Caffeine place conditioning in rats: comparison with cocaine and ethanol
Patkina, N. A., & Zvartau, E. E. (1998) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(97)00086-2 · Cited by 53
Involvement of adenosine A1 receptors in the discriminative-stimulus effects of caffeine in rats
Solinas, M., Ferré, S., Antoniou, K. M., Quarta, D., Justinová, Z., Hockemeyer, J., Pappas, L. A., Segal, P. N., Wertheim, C. E., Müller, C. E., et al. (2005) · Psychopharmacology · doi:10.1007/s00213-004-2081-6 · Cited by 52
Self-citationLack of tolerance to motor stimulant effects of a selective adenosine A2A receptor antagonist
Halldner, L., Lozza, G., Lindström, K., & Fredholm, B. B. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00682-8 · Cited by 52
ROLE OF ADENOSINE IN THE CONTROL OF HOMOSYNAPTIC PLASTICITY IN STRIATAL EXCITATORY SYNAPSES
Ferré, S., Borycz, J., Goldberg, S. R., Hope, B. T., Morales, M., Lluı́s, C., Franco, R., Ciruela, F., & Cunha, R. A. (2005) · Journal of Integrative Neuroscience · doi:10.1142/s0219635205000987 · Cited by 50
Self-citationKuzmin, A., Johansson, B. A., Giménez‐Llort, L., Ögren, S. O., & Fredholm, B. B. (2005) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2005.07.001 · Cited by 49
Ballarín, M., Reiriz, J., Ambrosio, S., & Mahy, N. (1995) · Neuroscience Letters · doi:10.1016/0304-3940(94)11217-7 · Cited by 49
Heterodimerization of G-protein-coupled receptors in the CNS
Marshall, F. H. (2001) · Current Opinion in Pharmacology · doi:10.1016/s1471-4892(01)00001-7 · Cited by 49
Cauli, O., Pinna, A., Valentini, V., & Morelli, M. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300240 · Cited by 48
Popoli, P. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00144-x · Cited by 45
Spealman, R. D. (1988) · Psychopharmacology · doi:10.1007/bf00212759 · Cited by 42
Adenosine receptor expression and function in rat striatal cholinergic interneurons
Preston, Z., Lee, K., Widdowson, L., Freeman, T. C., Dixon, A. K., & Richardson, P. J. (2000) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0703366 · Cited by 40
Brockwell, N. T., & Beninger, R. J. (1996) · Behavioural Pharmacology · doi:10.1097/00008877-199608000-00009 · Cited by 39
Behavioral effects of adenosine analogs in squirrel monkeys: relation to adenosine A2 receptors
Spealman, R. D., & Coffin, V. L. (1986) · Psychopharmacology · doi:10.1007/bf00179203 · Cited by 37
Adenosine receptors--the role in modulation of dopamine and glutamate release in the rat striatum.
Gołembiowska, K., & Żylewska, A. (1998) · PubMed · Cited by 35
Ferré, S., Rimondini, R., Popoli, P., Reggio, R., Pèzzola, A., Hansson, A. C., Andersson, A., & Fuxé, K. (1999) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.1999.00810.x · Cited by 32
Self-citationPsychostimulants and Vesicle Trafficking: A Novel Mechanism and Therapeutic Implications
Hanson, G. R., Sandoval, V., Riddle, E. L., & Fleckenstein, A. E. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1316.019 · Cited by 31
Adenosinergic modulation of the discriminative-stimulus effects of methamphetamine in rats
Munzar, P., Justinová, Z., Kutkat, S. W., Ferré, S., & Goldberg, S. R. (2002) · Psychopharmacology · doi:10.1007/s00213-002-1075-5 · Cited by 31
Self-citationHow habitual caffeine consumption and dose influence flavour preference conditioning with caffeine
Tinley, E. M., Durlach, P. J., & Yeomans, M. R. (2004) · Physiology & Behavior · doi:10.1016/j.physbeh.2004.03.018 · Cited by 23
Myers, K. P., & Izbicki, E. V. (2006) · Physiology & Behavior · doi:10.1016/j.physbeh.2006.05.010 · Cited by 23
Caffeine-reinforced conditioned flavor preferences in rats.
Fedorchak, P. M., Mesita, J., Plater, S. A., & Brougham, K. (2002) · Behavioral Neuroscience · doi:10.1037/0735-7044.116.2.334 · Cited by 19
Research works printed but not linked: 1
- Rall T. W., 1982, Evolution of the mechanism of action of methylxanthines from calcium mobilizers to antagonists of adenosine receptors, Pharmacologist, 24, 277
Cited by
Sorted by citations
The 2.6 Angstrom Crystal Structure of a Human A 2A Adenosine Receptor Bound to an Antagonist
Jaakola, V., Griffith, M. T., Hanson, M. A., Cherezov, V., Chien, E. Y. T., Lane, J. R., IJzerman, A. P., & Stevens, R. C. (2008) · Science · doi:10.1126/science.1164772 · Cited by 1,786
Heckman, M. A., Weil, J., & de Mejía, E. G. (2010) · Journal of Food Science · doi:10.1111/j.1750-3841.2010.01561.x · Cited by 1,116
“The blockage of adenosine to the neurons causes the sleep promoting effects of adenosine to stop, resulting in the neurons speeding up instead of slowing down (Ferre 2008).”
BackgroundKennedy, D. O., & Wightman, E. L. (2011) · Advances in Nutrition · doi:10.3945/an.110.000117 · Cited by 684
“Similarly, in mammals, caffeine is a competitive antagonist of inhibitory adenosine A1 and A2 receptors, which in turn leads to activation via increased dopaminergic and glutamatergic activity (64).”
BackgroundInterindividual Differences in Caffeine Metabolism and Factors Driving Caffeine Consumption
Nehlig, A. (2018) · Pharmacological Reviews · doi:10.1124/pr.117.014407 · Cited by 632
Scientific Opinion on the safety of caffeine
EFSA Panel on Dietetic Products, N. A. A. (. (2015) · EFSA Journal · doi:10.2903/j.efsa.2015.4102 · Cited by 613
“Prolonged administration of an adenosine A2A receptor antagonist does not induce tolerance to its motor stimulant effect, suggesting that caffeine tolerance may be dependent on blockade of A1, rather than A2A, receptors (Ferre, 2008).”
Background
Metadata
- Authors
- Ferré, S.
- Affiliations
- National Institutes of Health (US)
- Corresponding author
- Ferré, Sergi
- ORCID
- Ferré, Sergi
- Venue
- Journal of Neurochemistry
- Publisher
- Wiley
- Published
- 2007-12-18
- Volume
- 105
- Issue
- 4
- Pages
- 1067-1079
- ISSN
- 0022-3042 (ISSN-L)
- 1471-4159
- OpenAlex
- W1994970739
- Cited by
- 440
- References
- 129
- Citations by year
- 2026: 12 · 2025: 19 · 2024: 14 · 2023: 23 · 2022: 31 · 2021: 30 · 2020: 15 · 2019: 26 · 2018: 24 · 2017: 18 · 2016: 32 · 2015: 32 · 2014: 25 · 2013: 34 · 2012: 29
- FWCI
- 1.52
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Neurochemistry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute on Drug Abuse
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Physiology › Adenosine and Purinergic Signaling
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- caffeine, psychostimulant effects, adenosine receptors, adenosine A1 receptor, adenosine A2A receptor, receptor heteromers, dopamine signaling, glutamatergic synapses, dopamine D1 receptor, dopamine D2 receptor, motor activation, reinforcement, adenosine
- MeSH terms
- Adenosine, Central Nervous System Stimulants, Animals, Caffeine, Humans, Receptors, Purinergic P1, Purinergic P1 Receptor Agonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review